Guard Therapeutics International AB (publ) (STO:GUARD)

Sweden flag Sweden · Delayed Price · Currency is SEK
1.580
-0.020 (-1.25%)
At close: Mar 4, 2026
Market Cap31.86M -91.5%
Revenue (ttm)n/a
Net Income-108.85M
EPS-6.04
Shares Out20.17M
PE Ration/a
Forward PE0.69
Dividendn/a
Ex-Dividend Daten/a
Volume9,560
Average Volume32,120
Open1.600
Previous Close1.600
Day's Range1.510 - 1.600
52-Week Range1.100 - 27.000
Beta-0.20
RSI41.52
Earnings DateFeb 20, 2026

About STO:GUARD

Guard Therapeutics International AB (publ), a clinical-stage biotechnology company, identifies and develops medicines to treat kidney diseases in Sweden. Its pipeline products include RMC-035, an intact therapeutic A1M protein, that is in Phase 2b clinical trial for kidney protection with open-heart surgery; in Phase 2a clinical trial for kidney transplantation; and is in preclinical trial to treat Sepsis. It also develops GTZ peptides, a modified A1M-derived peptides which is in preclinical studies for the treatment of CKD and diabetes, heart ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2008
Employees 12
Stock Exchange Nasdaq Stockholm
Ticker Symbol GUARD
Full Company Profile

Financial Performance

Financial Statements